Clazakizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against interleukin-6.
Trade Name |
|
Common Name |
Clazakizumab |
Indication |
|
Drug Class |
Monoclonal antibodies: humanized, interleukins as target |